Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3829 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Ortho therapy effective in anemia

This study investigated the effect of Procrit at a dose of 20,000 units administered once every two weeks, on hemoglobin response in patients with anemia related to chronic

Shire phosphate binder successful in kidney patients

Most chronic kidney disease (CKD) stage 5 patients will develop high phosphorus levels in the blood known as hyperphosphatemia. Without effective treatment, hyperphosphatemia may lead to renal osteodystrophy,

J&J buys stent maker for $1.4 billion

The acquisition of Conor Medsystems will provide Cordis Corporation, a subsidiary of Johnson & Johnson with the cardiovascular treatment CoStar Stent System. The CoStar Stent is currently sold

EU voices concerns over Novartis fungal drug

This submission for European Union approval was made in 2005 by the UK biopharmaceuticals company NeuTec Pharma, which Novartis acquired in mid-2006 to expand its portfolio of compounds

Alfacell says Onconase shows anti-tumor activity

In the trial Onconase improved the efficacy of radiation therapy, resulting in significantly greater delay in tumor growth. Additionally, Onconase significantly induced apoptosis (programmed cell death) when administered

Evotec starts mid-stage insomnia trial

It is designed to assess the hypnotic efficacy of EVT 201 during seven nights’ treatment and also to determine the effect of improved sleep quality on daytime performance.